Scientific Publications by FDA Staff
Toxins 2011 Nov;3(11):1405-19
Llama-derived single domain antibodies specific for Abrus agglutinin.
Goldman ER, Anderson GP, Zabetakis D, Walper S, Liu JL, Bernstein R, Calm A, Carney JP, O'Brien TW, Walker JL, Garber EA
Llama derived single domain antibodies (sdAb), the recombinantly expressed variable heavy domains from the unique heavy-chain only antibodies of camelids, were isolated from a library derived from llamas immunized with a commercial abrin toxoid preparation. Abrin is a potent toxin similar to ricin in structure, sequence and mechanism of action. The selected sdAb were evaluated for their ability to bind to commercial abrin as well as abrax (a recombinant abrin A-chain), purified abrin fractions, Abrus agglutinin (a protein related to abrin but with lower toxicity), ricin, and unrelated proteins. Isolated sdAb were also evaluated for their ability to refold after heat denaturation and ability to be used in sandwich assays as both capture and reporter elements. The best binders were specific for the Abrus agglutinin, showing minimal binding to purified abrin fractions or unrelated proteins. These binders had sub nM affinities and regained most of their secondary structure after heating to 95 degrees C. They functioned well in sandwich assays. Through gel analysis and the behavior of anti-abrin monoclonal antibodies, we determined that the commercial toxoid preparation used for the original immunizations contained a high percentage of Abrus agglutinin, explaining the selection of Abrus agglutinin binders. Used in conjunction with anti-abrin monoclonal and polyclonal antibodies, these reagents can fill a role to discriminate between the highly toxic abrin and the related, but much less toxic, Abrus agglutinin and distinguish between different crude preparations.
|Category: Journal Article|
|PubMed ID: #22174977||DOI: 10.3390/toxins3111405|
|PubMed Central ID: #PMC3237003|
|Includes FDA Authors from Scientific Area(s): Food|
|Entry Created: 2012-10-04|